Depression and degree of acceptance of adjuvant cytotoxic drugs

Marco Colleoni, Mario Mandala, Giulia Peruzzotti, Chris Robertson, Anne Bredart, Aron Goldhirsch

Research output: Contribution to journalArticlepeer-review


An interaction between psychological attitude and outcome in early-stage breast cancer has been postulated, with a possible explanation related to the presumed tendency of depressed patients to be less proactive in obtaining health care. We report on the degree of acceptance of adjuvant chemotherapy in patients with breast cancer who have concomitant depression. Only 20 (51.3%) of the study group accepted and received the proposed chemotherapy compared with 75 (92.2%) of the control group (p

Original languageEnglish
Pages (from-to)1326-1327
Number of pages2
Issue number9238
Publication statusPublished - Oct 14 2000

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Depression and degree of acceptance of adjuvant cytotoxic drugs'. Together they form a unique fingerprint.

Cite this